Article Details

Pfizer Advances Daily Oral GLP-1 Agonist Danuglipron | Mirage News

Retrieved on: 2024-07-12 17:23:48

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Advances Daily Oral GLP-1 Agonist Danuglipron | Mirage News. View article details on hiswai:

Excerpt

Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its.

Article found on: www.miragenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up